期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

^(18)F-FDG PET/CT对胃癌术后的监测价值 被引量：5

The Value of ^(18)F-FDG PET/CT in Posttherapy Follow up of Stomach Cancer
下载PDF
导出
摘要 胃癌是发病率和死亡率均较高的恶性肿瘤,其主要死因为术后复发。常用的检测复发的手段无法全面准确地检测胃癌复发。18F-FDG PET/CT是功能与解剖相结合的非侵入性显像方法。本文就PET/CT对胃癌复发的监测价值进行总结。 Stomack cancer is one of the most common cancer with high incidence and morbidity. Death of stomach cancer is mainly due to cancer recurrence. However,routine follow up examination does not exactly detect recurrence before symptom development. PET / CT is a noninvasive imaging modality that provides both metabolic and anatomical information of tumors. The aim of this study was to summarize the value of ^18F-FDG PET / CT in post-therapy follow up of stomach cancer.
作者 沈维 邓胜明 章斌 潘律德 吴翼伟
机构地区 苏州大学附属第一医院核医学科
出处 《标记免疫分析与临床》 CAS 2016年第4期470-472,共3页 Labeled Immunoassays and Clinical Medicine
基金 苏州市科技发展计划(SYS201458)
关键词 ^18F-FDG PET/CT 胃癌 复发 监测 ^18F-FDG PET/CT Stomach cancer Recurrent Follow up
分类号 R735.2 [医药卫生—肿瘤] R730.44 [医药卫生—肿瘤]
  • 相关文献

参考文献2

二级参考文献19

  • 1唐磊,张晓鹏,孙应实,李英.胃癌磁共振扩散加权成像:并行采集联合分次屏气多信号平均技术的临床研究[J].中国医学影像技术,2005,21(12):1830-1834. 被引量：15
  • 2Cunningham D,Allum WH,Stenning SP,菅鑫妍.手术期间化学疗法与单独手术治疗可切除的胃食管癌疗效比较[J].中国处方药,2006,5(8):59-60. 被引量：434
  • 3黎功,郑静晨,于金明,付政,刘森,赵献光,宁健,韦光胜,陈少卿.^(18)F-FDG PET评价鼻咽癌放疗疗效[J].中华核医学杂志,2007,27(2):102-102. 被引量：3
  • 4Ychou M, Boige V, Pignon JP, et al. Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adeno- carcinoma: an FNCLCC and FFCD multicenter phase III trial[ J]. J Clin Oneol, 2011, 29: 1715-1721.
  • 5Nishino M, Jackman DM, Hatabu H, et al. New Response Evalua- tion Criteria in Solid Tumors (RECIST) guidelines for advanced non-small cell lung cancer: comparison with original RECIST and impact on assessment of tumor response to targeted therapy [ J ]. AJR Am J Roentgenol, 2010, 195: W221-228.
  • 6Chung HH, Kim JW, Han KH, et al. Prognostic value of metabolic tumor volume measured by FDG-PET/CT in patients with cervical cancer[J]. Gynecol Oncol, 2011, 120: 270-274.
  • 7Becker K, Mueller JD, Schulmacher C, et al. Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy[J]. Cancer, 2003, 98: 1521-1530.
  • 8Lorenzen S, yon Gall C, Stange A, et al. Sequential FDG-PET and induction chemotherapy in locally advanced adenocarcinoma of the Oesophago-gastricjunction (AEG): the Heidelberg Imaging pro-gram in Cancer of the oesophago-gastric junction during Neoadju- rant treatment: HICON trial[J]. BMC Cancer, 2011,11 : 266.
  • 9Ott K, Herrmann K, Lordick F, et al. Early metabolic response e- valuation by ^18F-fluorodeoxyglucose positron emission tomography allows in vivo testing of chemosensitivity in gastric cancer: long- term results of a prospective study [ J ]. Clin Cancer Res, 2008, 14: 2012-2018.
  • 10Kawamura T, Kusakabe T, Sugino T, et al. Expression of glucose transporter-1 in human gastric carcinoma: association with tumor aggressiveness, metastasis, and patient survival [ J]. Cancer, 2001, 92: 634-641.

共引文献16

同被引文献39

引证文献5

二级引证文献37

标记免疫分析与临床
2016年 第4期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部